A female prevalence among patients suspected clinically to have DS but withoutT21was documented in a chapter titled “Gender affects clinical suspicion of Down syndrome” in 2011. Since then no further studies followed probably because such patients have routinely been taken for carriers of undetected mosaicism due to either its very low level or the presence in other tissues unavailable for cytogenetic testing. Current report is intended to explain the difference between the mentioned patient cohorts